Legislator Case Law & Legislation
ln_2021_112 MT

Drugs (Control) (Amendment) Regulations, 2021

4 Articles / Provisions · Malta
Open official source Machine-readable Markdown (.md)

Statutory Text (4 Articles)

Malta Government Gazette — Legal Notice 2021 112 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Drugs (Control) (Amendment) Regulations, 2021

L.N. 112 of 2021

MEDICAL AND KINDRED PROFESSIONS ORDINANCE

(CAP. 31)

Drugs (Control) (Amendment) Regulations, 2021

IN EXERCISE of the powers conferred by article 40 of the

Medical and Kindred Professions Ordinance, the Minister for Health

after consultation with the Council of Health, has made the following

regulations:-

Malta Government Gazette — Legal Notice 2021 112 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Drugs (Control) (Amendment) Regulations, 2021

The title of these regulations is Drugs (Control) Citation.

(Amendment) Regulations, 2021 and these regulations shall be read

and construed as one with the Drugs (Control) Regulations, hereinafter S.L. 31.18.

referred to as "the principal regulations".

Malta Government Gazette — Legal Notice 2021 112 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Drugs (Control) (Amendment) Regulations, 2021

In the First Schedule to the principal regulations, there shall Amends the

First Schedule

be added the following

to the principal

regulations.

International or other

nonproprietary name or

Chemical name

other trivial name

"DOC

1-(4-chloro-2,5-dimethoxyphenyl)propan-

2-amine".

Malta Government Gazette — Legal Notice 2021 112 · Gazzetta tal-Gvern ta’ Malta Nru. 20,591 – 17.03.2021<P Class=Msonormal — Drugs (Control) (Amendment) Regulations, 2021

In the Second Schedule to the principal regulations, there Amends the

Second

shall be added the following

Schedule to the

principal

regulations.

International or other

nonproprietary name or

Chemical name

other trivial name

"AB-FUBINACA (or

N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-

FUB-AMB)

(4-fluorobenzyl)-1H-indazole-3-carboxam-

ide

5F-AMB-PINACA (or 5F- methyl 2-({[1-(5-fluoropentyl)-1H-indazole-

AMB or 5F-MMB-PIN-

3-yl]carbonyl}amino)-3-methylbutanoate

ACA)

5F-MDMB-PICA (or 5F- methyl 2-{[1-(5-fluoropentyl)-1H-indole-3-

carbonyl]amino}-3,3-dimethylbutanoate

MDMB-2201)

4F-MDMB-BINACA (or methyl 2-{[1-(4-fluorobutyl)-1H-indazole-3-

4F-MDMB-BUTINACA) carbonyl]amino}-3,3-dimethylbutanoate

4-CMC (or 4-chlorometh- 1-(4-chlorophenyl)-2-(methylamino)pro-

cathinone or clephedrone) pan-1-one

N-ethylhexedrone (or

2-(ethylamino)-1-phenylhexan-1-one

NEH, Hexen, Ethyl-Hex,

Ethyl-hexedrone)

Alpha-PHP (or PV-7, α-

1-phenyl-2-(pyrrolidin-1-yl)hexan-1-one

PHP, α-pyrrolidinohexan-

ophenone)

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-

Flualprazolam (or Ro 11-

[1,2,4]triazolo[4,3-a][1,4]benzodiazepine

5073/000)

Etizolam (or Y-7131 or

4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-

thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diaze-

Depas)

pine".

€0.18

Need to analyze how this provision applies to your matter?

Cross-reference this statute against case law, commentaries, and related legislative provisions inside Legislator AI.

Open in Legislator →